Patient Group Directions

Applied filters

Patient Group Directions

Care Setting (14)
- Emergency medicine and urgent care (5)
- Occupational Health (6)
- Palliative and End of Life Care (1)
- Primary Care (2)
Events (1)
- Past Events (1)
Guidance (150)
- Administering (10)
- Dosing (2)
- Medication Safety (1)
- Patient Group Directions (150)
- Policy, Commissioning and Managerial (8)
- Safety in Pregnancy (5)
- Service advice and planning (3)
- Supply (11)
- Unlicensed medicines (2)
Medicine (87)
- Aciclovir (2)
- Amoxicillin (1)
- Aspirin (1)
- Azithromycin (1)
- Benzylpenicillin (2)
- Ceftriaxone (1)
- Clarithromycin (5)
- Clotrimazole (2)
- Co-amoxiclav (1)
- Copper (1)
- Cytisinicline (1)
- Diamorphine (1)
- Diazepam (2)
- Doxycycline (4)
- Emtricitabine + Tenofovir alafenamide (1)
- Emtricitabine + Tenofovir disoproxil (1)
- Erythromycin (5)
- Estradiol + Dienogest (1)
- Estradiol + Nomegestrol (1)
- Ethinylestradiol + Desogestrel (1)
- Ethinylestradiol + Drospirenone (1)
- Ethinylestradiol + Etonogestrel (1)
- Ethinylestradiol + Gestodene (1)
- Ethinylestradiol + Levonorgestrel (1)
- Ethinylestradiol + Norelgestromin (1)
- Ethinylestradiol + Norethisterone (1)
- Ethinylestradiol + Norgestimate (1)
- Etonogestrel (2)
- Flucloxacillin (2)
- Fluconazole (1)
- Flumazenil (1)
- Fluticasone (1)
- Folic acid (1)
- Fusidic acid (1)
- Gadobutrol (1)
- Gadopiclenol (1)
- Gadoteric acid (1)
- Gadoteridol (1)
- Gadoxetic acid (1)
- Hydrogen peroxide (1)
- Hyoscine butylbromide (1)
- Imiquimod (1)
- Influenza vaccine (3)
- Iodixanol (1)
- Iohexol (1)
- Iomeprol (1)
- Iopamidol (1)
- Ioversol (1)
- Ketamine (1)
- Levonorgestrel (2)
- Lidocaine (5)
- Lidocaine + Prilocaine (1)
- Malathion (1)
- Medroxyprogesterone (2)
- Meglumine gadobenate (1)
- Metronidazole (2)
- Midazolam (2)
- Mifepristone (1)
- Misoprostol (1)
- Mometasone (1)
- Morphine (1)
- Nitrofurantoin (1)
- Permethrin (1)
- Phenoxymethylpenicillin (2)
- Podophyllotoxin (1)
- Prilocaine (1)
- Progesterone (1)
- Raltegravir (1)
- Sodium chloride (1)
- Tenofovir disoproxil + Emtricitabine (1)
- Terbutaline (1)
- Tramadol (1)
- Tranexamic acid (1)
- Trimethoprim (1)
- Ulipristal (1)
- Valaciclovir (1)
- Varenicline (1)
Publications (93)
- Explainer videos (4)
- Research and audits (3)
- Templates (86)
Specialty (78)
- Infection and infectious diseases (30)
- Neurological disorders (1)
- Obstetrics and gynaecology (1)
- Public Health (1)
- Radiology (13)
- Renal and urologic disorders (2)
- Reproductive health (14)
- Respiratory disorders (13)
- Sexual health (14)
- Skin disorders (14)
- Smoking cessation (2)
- Vaccinating (3)
Training and Development (6)

Iomeprol contrast agent

11 February 2026SPS PGD template for administering iomeprol intravenously for imaging investigations and procedures by registered Radiographers.

Use of PGDs by trainee registered healthcare professionals

12 February 2026Advice on the use of Patient Group Directions by registered healthcare professionals who are undertaking training and/or competency assessment

Progestogen only pill (POP) for contraception

12 February 2026SPS PGD template for the supply of a progestogen only pill (POP) for contraception.

Lidocaine plus prilocaine cream for IUD insertion or removal

12 February 2026SPS protocol template for the administration of lidocaine plus prilocaine cream to facilitate intrauterine device (IUD) insertion or removal.

Including medicines with Risk Minimisation Measures (RMM) in PGDs

10 November 2025Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.

Patient Group Directions in Complex Commissioning Scenarios

8 April 2024This guide supports planning, decision making and advises on governance processes when PGDs are used within commissioned services.

Retaining legal mechanism documentation

30 April 2025Advice on the retention of all records relating to legal mechanisms, such as PSDs, PGDs, Written Instructions and National Protocols

Managing Patient Group Directions following amendments or changes

8 April 2024There are requirements for all PGDs to be resigned or reauthorised after any amendment or change made during its valid to/from dates

Supply and/or administration of Controlled Drugs under a PGD

2 June 2025The legal position on the supply and/or administration of controlled drugs under Patient Group Directions is summarised

Extension of expiry date of a Patient Group Direction

10 November 2025This article advises on the extension to the expiry date of a PGD where a full review and re-authorisation has not taken place.